Today Got Better
Subscribe

Technology & Innovation Active Updated Jul 8, 2026

A vaccine built for coronaviruses we have not met yet

Researchers used AI to scan thousands of sarbecovirus genomes and identify conserved targets evolution has left largely untouched across SARS, COVID-19, and bat coronaviruses that have not yet jumped to humans. The resulting DNA vaccine, stable without refrigeration and delivered needle-free, has entered its first human trial.

The story so far

  1. Jul 8, 2026 Latest

    Researchers at the University of Cambridge used AI to scan genetic data from thousands of sarbecoviruses, identify conserved targets a virus is unlikely to mutate without losing fitness, and design a DNA vaccine stable without refrigeration and delivered via needle-free high-pressure liquid injection. The vaccine entered human trials for the first time, aiming to protect against the entire sarbecovirus family including strains that do not yet exist.

    Today Got Better

This story moves with the morning letter.

When this arc advances, the timeline above grows the same morning. One short, warm letter with the day's real progress in science, medicine and beyond. Free, every day.